Kemal Kucuk, | |
252 Mchenry St, Burlington, WI 53105-1828 | |
(262) 767-6000 | |
Not Available |
Full Name | Kemal Kucuk |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 8 Years |
Location | 252 Mchenry St, Burlington, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053844142 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 72984 (Wisconsin) | Primary |
207R00000X | Internal Medicine | 72984 (Wisconsin) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Aspirus Riverview Hospital & Clinics Inc | Wisconsin rapids, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aspirus Riverview Hospital And Clinics Inc | 4587658182 | 144 |
Aspirus Wausau Hospital Inc | 6406757442 | 173 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Marshfield Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Aspirus Wausau Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922321140 PECOS PAC ID: 6406757442 Enrollment ID: O20040114000297 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Beaver Dam Community Hospitals Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972188555 PECOS PAC ID: 2567370539 Enrollment ID: O20040210000666 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Aspirus Riverview Hospital & Clinics Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295754844 PECOS PAC ID: 4587658182 Enrollment ID: O20040414000945 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Howard Young Medical Center Inc Of Woodruff Wisconsin |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184673352 PECOS PAC ID: 4183519606 Enrollment ID: O20040419000970 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Memorial Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20040519001426 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Flambeau Hospital, Inc. |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1700963048 PECOS PAC ID: 9032029871 Enrollment ID: O20070828000478 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Memorial Hospital Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1346239373 PECOS PAC ID: 2365433224 Enrollment ID: O20110526000807 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Mchs Hospitals Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Eastern Wisconsin Medical Company Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831604081 PECOS PAC ID: 0143583021 Enrollment ID: O20180405001063 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Lakeview Medical Center Inc Of Rice Lake |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093201832 PECOS PAC ID: 6103737820 Enrollment ID: O20180817001484 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Mchs Hospitals Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1952890873 PECOS PAC ID: 5698071173 Enrollment ID: O20180904002962 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Flambeau Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194317966 PECOS PAC ID: 9032029871 Enrollment ID: O20210409000059 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Entity Name | Usa Vein Clinics Of Wisconsin Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033806534 PECOS PAC ID: 3779943949 Enrollment ID: O20230719002812 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Kemal Kucuk, 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (414) 389-2233 | Kemal Kucuk, 252 Mchenry St, Burlington, WI 53105-1828 Ph: (262) 767-6000 |
News Archive
According to "Women Talk," the first annual national women's health survey from the National Women's Health Resource Center (NWHRC), being healthy to women means both physical and emotional wellness and having a healthy family and suggests that women place a greater priority on the health of their family than their own personal health.
Bristol-Myers Squibb Company announced today that belatacept, an investigational selective T cell co-stimulation blocker being studied for use in solid organ transplantation, will be the subject of eight clinical presentations related to kidney transplantation at the American Transplant Congress, being held May 1 - 5 in San Diego.
ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.
In research published in Nature Chemical Biology, scientists from RIKEN in Japan have discovered a surprisingly simple mechanism through which enterics can adjust to the very different oxygen environments inside the human gut and outside.
› Verified 4 days ago
Nicholas Christian Otten, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-767-6000 | |
Dr. Preethi Donakonda, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-767-8000 | |
Rajbir Dhillon, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-767-6000 |